An overview of the clinical use of ondansetron in preschool age children

Therapeutics and Clinical Risk Management

Volumn 3, Issue 2, 2007, Pages 333-339

  Cohen, Ira Todd ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Chemotherapy; Children; Gastroenteritis; Nausea; Ondansetron; Postoperative nausea and vomiting; Preschool; Vomiting

Indexed keywords

ANESTHETIC AGENT; ANTIEMETIC AGENT; ASPARAGINASE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHOLINESTERASE INHIBITOR; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; DROPERIDOL; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; METHOTREXATE; METOCLOPRAMIDE; MITOMYCIN; MITOXANTRONE; NEUROTRANSMITTER; NITROUS OXIDE; ONDANSETRON; OPIATE; UNINDEXED DRUG;

AGE; ANTIEMETIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CHILD CARE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFUSION; DISEASE CONTROL; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG USE; DYSKINESIA; DYSPHORIA; DYSTONIA; ECG ABNORMALITY; EXTRAPYRAMIDAL SYMPTOM; GASTROENTERITIS; HEART ARRHYTHMIA; HIGH RISK POPULATION; HUMAN; MEDICAL RESEARCH; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; PEDIATRIC ANESTHESIA; POSTOPERATIVE NAUSEA AND VOMITING; PRACTICE GUIDELINE; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; VIRUS INFECTION;

EID: 34250006794     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: 10.2147/tcrm.2007.3.2.333     Document Type: Review

References (71)

1. Aapro M. 2005. 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology, 69:97-109.
2. Alexander R, Lovell AT, Seingry D, et al. 1995. Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia, 50:1086-8.
3. Alvarez O, Freeman A, Bedros A, et al. 1995. A double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol, 17:145-50.
4. Andrews PL, Hawthorn J. 1988. The neurophysiology of vomiting. Res Clin Gastroenterol, 2:141-68.
5. Anonymous. 1987. 5-HT3 receptor antagonists: a new class of antiemetics. Lancet, 1(8548):1470-1.
6. Anonymous. 1996. Practice parameter: the management of acute gastroenteritis in young children. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Pediatrics, 97:424-35.
7. Anonymous. 2004. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. Pediatrics, 114: 507.
8. Antonarakis ES, Evans JL, Heard GF, et al. 2004. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence? Pediatr Blood Cancer, 43:651-8.
9. Binstock WI, Rubin R, Bachman C, et al. 2004. The effect of premedication with OTFC, with or without ondansetron, on postoperative agitation, and nausea and vomiting in pediatric ambulatory patients Paediatr Anaesth, 14:759-67.
10. Campora E, Merlini L, Pace M, et al. 1991. The incidence of narcotic-induced emesis. J Pain Symptom Manage, 6:428-30.
11. Coates A, Abraham S, Kaye SB, et al. 1983. On the receiving end: patients' perception of cancer chemotherapy. Eur J Cancer Clin Oncol, 19:203-8.
12. Cohen MM, Cameron CB, Duncan PG. 1990. Pediatric anesthesia morbidity and mortality in the perioperative period. Anesth Analg, 70:160-7.
13. Culy CR, Bhana N, Plosker GL. 2001. Ondansetron: a review of its use as an antiemetic in children. Pediatric Drugs, 3:441-479.
14. Dick GS, Meller ST, Pinkerton CR. 1995. Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child, 73:243-5.
15. Domino KB, Anderson EA, Polissar NL, et al. 1999. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg, 88:1370-9.
16. Dupuis LL, Nathan PC. 2003. Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. Pediatric Drugs. 5:597-613.
17. Eberhart LH, Morin AM, Wulf H, et al. 2002. Patient preferences for immediate postoperative recovery. Br J Anaesth, 89:760-1.
18. Figueredo E, Canosa L. 1999. Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. Eur J Anaesthesiol, 16:556-64.
19. Foot ABM, Hayes C. 1994. Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis. Arch Dis Child, 71:475-80.
20. Gan TJ. 2005. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs, 19:225-38.
21. Gan TJ, Meyer T, Apfel CC, et al. 2003. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg, 97:62-71.
22. Gold BS, Kitz DS, Lecky JH, et al. 1989. Unanticipated admission to the hospital following ambulatory surgery. JAMA, 262:3008-10.
23. Goodin S, Cunningham R. 2002. 5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Oncologist, 7:424-36.
24. Green JA, Watkin SW, Hammond P, et al. 1989. The efficacy and safety of GR38032F in the prophylaxis of ifosfamide-induced nausea and vomiting. Cancer Chemother Pharmacol, 24:137-40.
25. Habib AS, Gan TJ. 2001. Combination therapy for postoperative nausea and vomiting: a more effective prophylaxis? Amb Surg, 9:59-71.
26. Henzi I, Walder B, Tramer MR. 1999. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth, 83:761-71.
27. Henzi I, Walder B, Tramer MR. 2000. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg, 90:186-94.
28. Hesketh PJ, Kris MG, Grunberg SM, et al. 1997. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol, 15:103-9.
29. Hirayama T, Ishii F, Yago K, et al. 2001. Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: a quantitative systematic review. Yakugaku Zasshi, 121:179-85.
30. Holdsworth MT, Raisch DW, Duncan MH, et al. 1995. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. Ann Pharmacother, 29:16-21.
31. Holdsworth MT, Raisch DW, Frost J. 2006. Acute and delayed nausea and emesis control in pediatric oncology patients. Cancer, 106:931-40.
32. Iacono G, Merolla R, D'Amico D, et al. 2005. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis, 37:432-8.
33. Jaing T-H, Tsay P-K, Hung I-J, et al. 2004. Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based in pediatric outpatients with acute lymphoblastic leukemia. Pediatr Hematol Oncol, 21:227-35.
34. Jurgens H, McQuade B. 1992. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology, 49:279-85.
35. Khalil SN, Roth AG, Cohen IT, et al. 2005. A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesia. Anesth Analg, 101:356-61.
36. King CK, Glass R, Bresee JS, et al. 2003. Centers for disease control and prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep, 52:1-16.
37. Koseoglu V, Kurekci AE, Sarici U, et al. 1998. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr, 157:806-10.
38. Kovac AL, O'Connor TA, et al. 1999. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. J Clin Anesth, 11:453-9.
39. Kusnierczyk NM, Saunders EF, Dupuis LL. 2002. Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation. Bone Marrow Transplant, 30:119-24.
40. Lee A, Gin T, Lau AS, et al, 2005. A comparison of patients' and health care professionals' preferences for symptoms during immediate postoperative recovery and the management of postoperative nausea and vomiting. Anesth Analg, 100:87-93.
41. Leeser J, Lip H. 1991. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist. Anesth Analg, 72:751-5.
42. Lerman J. 1992. Surgical and patient factors involved in postoperative nausea and vomiting. Br J Anaesth, 69:24S-32.
43. Litman RS, Wu CL, Catanzaro FA. 1994. Ondansetron decreases emesis after tonsillectomy in children. Anesth Analg, 78:478-81.
44. Mercadante S, Sapio M, Serretta R. 1998. Ondansetron in nausea and vomiting induced by spinal morphine. J Pain Symptom Manage, 16:259-62.
45. Munro FJ, Fisher S, Dickson U, et al. 2002. The addition of antiemetics to the morphine solution in patient controlled analgesia syringes used by children after an appendicectomy does not reduce the incidence of postoperative nausea and vomiting. Paediatr Anaesth, 12:600-3.
46. Panda NB, Bharadwaj N, Kapoor P, et al. 2004. Prevention of nausea and vomiting after middle ear surgery: combination of ondansetron and dexamethasone is the right choice. J Otolaryngol, 33:88-92.
47. Pashar UD, Holman RC, Bresee JS, et al. 1998. Epidemiology of diarrheal disease among children in four West Coast health maintenance organizations. Pediatr Infect Dis J, 17:605-11.
48. Parker RI, Prakash D, Mahan RA, et al. 2001. Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children. J Pediatr Hematol Oncol, 23:578-81.
49. Patel RI, Hannallah RS. 1988. Anesthetic complications following pediatric ambulatory surgery: a 3-year study. Anesthesiology, 69:1009-12.
50. Pisters KM, Kris MG. 1998. Treatment-related nausea and vomiting. In: Berger A, Portenoy RK, Weissman DE (eds). Principles and practice of supportive oncology. Philadelphia, PA: Lippincott-Raven Publishers.
51. Pitkanen MT, Numminen MK, Tuominen MK, et al. 1997. Comparison of metoclopramide and ondansetron for the prevention of nausea and vomiting after intrathecal morphine. Eur J Anaesthesiol, 14:172-7.
52. Ramsook C, Sahagun-Carreon I, Kozinetz CA, et al. 2002. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med, 39:397-403
53. Reeves JJ, Shannon MW, Fleisher GR. 2002. Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized, controlled trial. Pediatrics, 109:62.
54. Roberts JT, Priestman TJ. 1993. A review of ondansetron in the management of radiotherapy-induced emesis. Oncology, 50:173-9.
55. Sanchez-Ledesma MJ, Lopez-Olaondo L, Pueyo FJ, et al. 2002. A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting. Anesth Analg, 95:1590-5.
56. Schnell FM. 2003. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist, 8:187-98.
57. Setness PA, Van Beusekom M. 2004. Patient Notes: motion sickness. Postgrad Med, 116:64.
58. Splinter W, Roberts DJ. 1997. Prophylaxis for vomiting by children after tonsillectomy: dexamethasone versus perphenazine. Anesth Analg, 85:534-7.
59. Steward DL, Welge JA, Myer CM. 2003. Steroids for improving recovery following tonsillectomy in children. Cochrane Database Syst Rev, 1:CD003997.
60. Stiakaki E, Savvas S, Lydaki E, et al. 1999. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol, 16:101-8.
61. Sussman G, Shurman J, Creed MR, et al. 1999. Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group. Clin Ther, 21:1216-27.
62. Tramer MR. 2001. A rational approach to the control of postoperative nausea and vomiting: evidence from systemic reviews. II. Recommendations for prevention and treatment and research agenda. Acta Anaesthesiol Scand, 45:14-19.
63. Tramer MR, Reynolds DJ, Moore RA, et al. 1997. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology, 87:1277-89.
64. Tramer MR, Reynolds DJ, Stoner NS, et al. 1998. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review. Eur J Cancer, 34:1836-44.
65. Tramer MR, Walder B. 1999 Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy: a quantitative systematic review. Anesth Analg, 88:1354-61.
66. Tyc VL, Mulhern RK, Bierberich AA. 1997. Anticipatory nausea and vomiting in pediatric cancer patients: an analysis of conditioning and coping variables. J Dev Behav Pediatr, 18:27-33.
67. Tzeng JI, Chu KS, Ho ST, et al. 2003. Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control. Can J Anaesth, 50:1023-6.
68. Watcha MF, White PF. 1992. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology, 77:162-84.
69. White LA, Vanarase M, Brockbank K, et al. Patient-controlled analgesia and postoperative nausea and vomiting: efficacy of a continuous infusion of ondansetron. Anaesth, 56:365-9.
70. Wisselo TL, Stuart C, Muris P. 2004. Providing parents with information before anaesthesia: what do they really want to know? Paediatr Anaesth, 14:299-307.
71. Zun LS, Downey LV, Gossman W, et al. 2002. Differences in narcotic-induced emesis in the ED. Am J Emerg Med, 20:151-4.